These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 3062823
1. [Clinical effectiveness of naftidrofuryl in intermittent claudication]. Kriessmann A, Neiss A. Vasa Suppl; 1988; 24():27-32. PubMed ID: 3062823 [No Abstract] [Full Text] [Related]
2. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage]. Valentin A, Karnik R, Stöllberger C, Slany J. Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493 [No Abstract] [Full Text] [Related]
8. Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using Naftidrofuryl tablets 200 mg. Adhoute G, Bacourt F, Barral M, Cardon JM, Chevalier JM, Cuny A, Gillet M, Juhan C, Leguay G, Marion J. Angiology; 1986 Mar 11; 37(3 Pt 1):160-7. PubMed ID: 3518547 [Abstract] [Full Text] [Related]
9. [Effectiveness of Dusodril-Pi in arterial occlusive diseases. A multicentric double-blind study]. Becker HM, Elert O, Häring R, Maurer PC, Raithel D, Sperling M, Stockmann U, Storz LW, Hirche H. Med Welt; 1979 Oct 26; 30(43):1602-6. PubMed ID: 514039 [No Abstract] [Full Text] [Related]
11. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS). Kieffer E, Bahnini A, Mouren X, Gamand S. Int Angiol; 2001 Mar 26; 20(1):58-65. PubMed ID: 11342997 [Abstract] [Full Text] [Related]
12. Effects of naftidrofuryl in patients with intermittent claudication. Karnik R, Valentin A, Stöllberger C, Slany J. Angiology; 1988 Mar 26; 39(3 Pt 1):234-40. PubMed ID: 3281516 [Abstract] [Full Text] [Related]
14. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease]. Horsch S. Vasa Suppl; 1988 Mar 26; 24():38-43. PubMed ID: 3212602 [No Abstract] [Full Text] [Related]
16. [Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia]. Cucinotta D, Dall'Asta D, Benaglia F, Barbagallo M, Butturini L, Pioli G, Salomone M. G Clin Med; 1985 Mar 26; 66(11-12):467-76. PubMed ID: 3835091 [No Abstract] [Full Text] [Related]
19. Naftidrofuryl: a review of its use in the treatment of intermittent claudication. Goldsmith DR, Wellington K. Drugs Aging; 2005 Mar 26; 22(11):967-77. PubMed ID: 16323973 [Abstract] [Full Text] [Related]
20. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease]. Pohle W, Hirche H, Barmeyer J, Schümichen C, Hoffmann G. Med Welt; 1979 Feb 16; 30(7):269-72. PubMed ID: 372733 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]